Doc. No.: INS/GDL/001-(Annexes)
UNAIDS Joint United Nations Programme on HIV/AIDS
The following protocol has been designed to investigate the First Few X cases (FFX) and their close contacts. It is envisioned that the FFX 2019-nCoV investigation will be conducted across several countries or sites with geographical and demographical diversity. Using a standardized protocol such a...s the protocol provided here, epidemiological exposure data and biological samples can be systematically collected and shared rapidly in a format that can be easily aggregated, tabulated and analyzed across many different settings globally for timely estimates of 2019-nCoV infection severity and transmissibility, as well as to inform public health responses and policy decisions. This is particularly important in the context of a novel respiratory pathogen, such as 2019-nCoV
more
Antimicrobial Resistance (AMR) occurs when organisms that cause disease are no longer susceptible/responsive to antimicrobial agents that previously were effective in combating them. AMR is a global problem with particularly dire consequences for Africa which is already grappling with high levels ...of infection in the face of limited resources.
more
Faith-based organizations (FBOs) and leaders can play a major role in saving lives and reducing illness related to COVID-19. They are a primary source of support and comfort for their members. Often trusted more than governments or health-agencies, faith leaders can share health information to prot...ect their communities that will be more likely to be accepted than from other sources.
By sharing simple steps to prevent COVID-19 faith organizations can promote helpful information, reduce fear and stigma, and provide reassurance to people in their communities. Because faith leaders are integrated into their communities through service and compassionate networks, they are often able to reach the most vulnerable among us with assistance and health information. In short, they are a critical link in the safety net for vulnerable people in their communities.
more
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re...sistance Surveillance System (GLASS), the first global collaborative effort to foster AMR surveillance in bacteria causing acute infections. As of December 2018, 71 countries are enrolled in GLASS. The aim of this report is to document participation efforts and outcomes across these countries, and highlight differences and constraints identified to date. This report follows on from the first GLASS Report – Early implementation 2016-17, published in January 2018, and drawing on data from GLASS first data call in 2017.
more
Key highlights from January to April 2020 (Syria situation)
Across the MENA region, UNHCR is receiving alarming reports of increasing mental health issues among the forcibly displaced. Mental health and psychosocial support (MHPSS) activities are being stepped up by UNHCR and partners to address th...is new dangerous trend.
more
Global procurement for COVID-19 vaccines
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...method, nucleic acid amplification tests (NAATs). This interim guidance offers recommendations on the priority uses of antigen-detecting rapid diagnostic tests (Ag-RDTs) in specific populations and settings, including (i) for primary case detection in symptomatic individuals suspected to be infected and asymptomatic individuals at high risk of COVID-19, (ii) for contact tracing, (iii) during outbreak investigations and (iv) to monitor trends of disease incidence in communities. Ag-RDTs meeting minimum performance requirements can be used outside of clinical and laboratory settings, including in communities, by trained operators in accordance with instructions. The guidance additionally provides recommendations on implementation, product selection and storage.
more
Contact tracing – along with robust testing, isolation and care of cases – is a key strategy for interrupting chains of transmission of SARS-CoV-2 and reducing mortality associated with COVID-19.
Обновленная версия Декабрь 2020 г.
The new Global AIDS Strategy 2021–2026, End Inequalities, End AIDS, is a bold approach that uses an inequalities lens to close the gaps preventing progress to end AIDS
The Democratic Republic of the Congo (DRC) is one of the most complex and long-standing humanitarian crises in Africa. By the end of 2020, some 940,421 Congolese refugees and asylum seekers were hosted across the African continent. Ongoing conflicts in eastern DRC, as well as intercommunal violence,... continue to cause forced displacement within the DRC and into neighbouring countries, along with tragic loss of human life and destruction of communities.
more
Person-centred evidence based practice (EBP)- Clinical Pocket Reference - for students, nurses and other healthcare professionals
A Book for Midwives > Chapter 20: The Pelvic Exam: how to examine a woman's vagina and womb > Cancer of the cervix
Geflüchtete Menschen, die bei uns Schutz suchen, haben häufig Bürgerkrieg, Verfolgung und Gewalt erlebt, ein Teil von ihnen leidet an psychisch reaktiven Traumafolgestörungen, die im Asylverfahren oftmals nur unzureichend bemerkt werden, was ihre Chancen einschränkt, einen sicheren Aufenthalt z...u erhalten.
more
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, resources, regulatory structures and processes and out...comes relating to the pharmaceutical sector in Kenya.
more
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.